Zylox-Tonbridge Medical Technology Co (HKSE:02190) COGS-to-Revenue : 0.28 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co COGS-to-Revenue?

Zylox-Tonbridge Medical Technology Co's Cost of Goods Sold for the six months ended in Dec. 2024 was HK$125.5 Mil. Its Revenue for the six months ended in Dec. 2024 was HK$444.7 Mil.

Zylox-Tonbridge Medical Technology Co's COGS to Revenue for the six months ended in Dec. 2024 was 0.28.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Zylox-Tonbridge Medical Technology Co's Gross Margin % for the six months ended in Dec. 2024 was 71.79%.

Zylox-Tonbridge Medical Technology Co COGS-to-Revenue Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co COGS-to-Revenue Chart

Zylox-Tonbridge Medical Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.41

0.26

0.24

0.27

0.28

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial						0.24	0.26	0.28	0.29	0.28

Zylox-Tonbridge Medical Technology Co COGS-to-Revenue Calculation

Zylox-Tonbridge Medical Technology Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	237.644	/	835.428
	=	0.28

Zylox-Tonbridge Medical Technology Co's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	125.455	/	444.67
	=	0.28

Zylox-Tonbridge Medical Technology Co (HKSE:02190) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Zylox-Tonbridge Medical Technology Co's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	125.455 / 444.67
	=	71.79 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Zylox-Tonbridge Medical Technology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Zylox-Tonbridge Medical Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

818:Germany

Address

270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.zyloxtb.com

Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). It derives majority of its revenue from PRC.

Executives

Wea Enterprises, Llc	2401 A concert party to an agreement to buy shares
Zhu Hai Tong Qiao Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Hang Zhou Fu Jiang Tou Zi He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhu Hai Gui Chuang Gu Quan Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Hang Zhou Gui Qiao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Hang Zhou Yu Yi Hui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhong Shengping Sam	2401 A concert party to an agreement to buy shares
Zhao Jonathon Zhong	2501 Other
Wei Na	2501 Other
Li Zheng	2501 Other
Wang Stephen Hui	2201 Interest of corporation controlled by you
Hu Zhou Yu Yi Hui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Schroders Plc	2102 Investment manager
Highlight Medical Limited	2501 Other
Ourea Biotech Hk Limited	2501 Other

Zylox-Tonbridge Medical Technology Co Headlines

No Headlines